| SEQUENCE: RAFL05-17-P08_1_ORF2 CRC64: 277A5EF778146B10 LENGTH: 57 aa | |||||||
| noIPR unintegrated |
| ||||||
| SEQUENCE: RAFL05-17-P08_1_ORF3 CRC64: A8077BB0FEFDA03A LENGTH: 51 aa | |||||||
| noIPR unintegrated |
| ||||||
| SEQUENCE: RAFL05-17-P08_2_ORF1 CRC64: 71FF6CEC0DBC44B6 LENGTH: 60 aa | |||||||
| noIPR unintegrated |
| ||||||
| SEQUENCE: RAFL05-17-P08_3_ORF1 CRC64: DF0C94F08CB95808 LENGTH: 353 aa | ||||||||||||||||
| InterPro IPR004331 Domain |
| |||||||||||||||
| noIPR unintegrated |
| |||||||||||||||
| SEQUENCE: RAFL05-17-P08_3_ORF2 CRC64: DF731FBC74AFCE4E LENGTH: 62 aa | |
| No hits reported. |
| SEQUENCE: RAFL05-17-P08_4_ORF2 CRC64: E1D8A3D2CF008811 LENGTH: 63 aa | |
| No hits reported. |
| SEQUENCE: RAFL05-17-P08_4_ORF3 CRC64: AFB93663BE62D760 LENGTH: 67 aa | |||||||
| noIPR unintegrated |
| ||||||
| SEQUENCE: RAFL05-17-P08_5_ORF2 CRC64: C3091821DB7033C0 LENGTH: 51 aa | |
| No hits reported. |
| SEQUENCE: RAFL05-17-P08_5_ORF3 CRC64: 5F2D0ADF96C2EFBF LENGTH: 50 aa | |||||||
| noIPR unintegrated |
| ||||||
| SEQUENCE: RAFL05-17-P08_6_ORF2 CRC64: CD4EE82856684BC6 LENGTH: 50 aa | |
| No hits reported. |
| SEQUENCE: RAFL05-17-P08_6_ORF3 CRC64: B2B1C0B7F3076605 LENGTH: 82 aa | |||||||
| noIPR unintegrated |
| ||||||
![[6-23]? NA seg seg](http://pmix.psc.riken.jp/img/interpro/G.gif){kind=small}
![[36-162]T 7.3e-21 PF03105 SPX](http://pmix.psc.riken.jp/img/interpro/H.gif){kind=small}
![[36-222]T 27.879 PS51382 SPX](http://pmix.psc.riken.jp/img/interpro/M.gif){kind=small}
![[168-336]T 4.1e-45 PTHR10783 XENOTROPIC AND POLYTROPIC MURINE LEUKEMIA VIRUS RECEPTOR](http://pmix.psc.riken.jp/img/interpro/X4.gif){kind=small}